Iria Testa-Novoa

A Coruna, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly.

Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: September 13, 2025

Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly.

Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly.

Journal: Pituitary

Published: August 23, 2025

Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study.

Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study.

Journal: Hormones (Athens, Greece)

Published: April 17, 2025

Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas.

Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas.

Journal: Endocrine connections

Published: February 20, 2025

Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study.

Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study.

Journal: Pituitary

Published: November 01, 2024

ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Journal: Endocrine-related cancer

Published: July 26, 2024

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.

Glucose metabolism outcomes after pituitary surgery in patients with acromegaly.

Journal: Pituitary

Published: June 15, 2024

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion.

Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion.

Journal: European journal of endocrinology

Published: March 11, 2024

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs.

Journal: Endocrine-related cancer

Published: March 02, 2024

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.

Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 20, 2023

Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population.

Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 09, 2022

Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain.

Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain.

Journal: Frontiers in endocrinology

Published: July 02, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026